High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

S Chow (Contributor)
V Galvis (Contributor)
M Pillai (Contributor)
R Leach (Contributor)
E Keene (Contributor)
A Spencer-Shaw (Contributor)
A Shablak (Contributor)
J Shanks (Contributor)
T Liptrot (Contributor)
F Thistlethwaite (Contributor)
Robert Hawkins (Contributor)

Division of Cancer Sciences (L5)

Dataset

1 Article

1 results

2016
High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome
Chow, S., Galvis, V., Pillai, M., Leach, R., Keene, E., Spencer-Shaw, A., Shablak, A., Shanks, J., Liptrot, T., Thistlethwaite, F. & Hawkins, R., 18 Oct 2016, In: Journal for ImmunoTherapy of Cancer. 4, 67
Research output: Contribution to journal › Article › peer-review

Open Access